Burçak Vural

779 total citations
38 papers, 566 citations indexed

About

Burçak Vural is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Burçak Vural has authored 38 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Neurology and 7 papers in Oncology. Recurrent topics in Burçak Vural's work include Multiple Sclerosis Research Studies (6 papers), Ocular Diseases and Behçet’s Syndrome (6 papers) and Systemic Lupus Erythematosus Research (5 papers). Burçak Vural is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Ocular Diseases and Behçet’s Syndrome (6 papers) and Systemic Lupus Erythematosus Research (5 papers). Burçak Vural collaborates with scholars based in Türkiye, United Kingdom and United States. Burçak Vural's co-authors include Uğur Özbek, Zeynep Tümer, Nina Horn, Connie Lund, Ali O. Güre, Ayşe Demirkan, Erdem Tüzün, T. Tønnesen, Anthony P. Monaco and Zeki Üstüner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Burçak Vural

33 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burçak Vural Türkiye 12 251 132 92 88 71 38 566
Godfrey T. Gillett United Kingdom 13 286 1.1× 138 1.0× 88 1.0× 30 0.3× 21 0.3× 20 677
Kris Mann United States 7 209 0.8× 79 0.6× 48 0.5× 88 1.0× 19 0.3× 10 635
Furu Wang China 13 278 1.1× 31 0.2× 163 1.8× 82 0.9× 60 0.8× 29 707
J Feingold France 15 287 1.1× 72 0.5× 45 0.5× 29 0.3× 81 1.1× 42 695
Ben Pode‐Shakked Israel 15 330 1.3× 73 0.6× 26 0.3× 18 0.2× 42 0.6× 54 620
Frederick Durham United States 5 400 1.6× 49 0.4× 34 0.4× 266 3.0× 22 0.3× 6 786
Erich Wichmann Germany 8 183 0.7× 18 0.1× 44 0.5× 50 0.6× 102 1.4× 13 645
Amir Aghajanian United States 11 295 1.2× 15 0.1× 69 0.8× 61 0.7× 61 0.9× 15 627
Karen Verity Australia 12 233 0.9× 49 0.4× 53 0.6× 19 0.2× 12 0.2× 12 568
Riccardo Albertini Italy 10 389 1.5× 43 0.3× 71 0.8× 9 0.1× 29 0.4× 11 658

Countries citing papers authored by Burçak Vural

Since Specialization
Citations

This map shows the geographic impact of Burçak Vural's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burçak Vural with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burçak Vural more than expected).

Fields of papers citing papers by Burçak Vural

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burçak Vural. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burçak Vural. The network helps show where Burçak Vural may publish in the future.

Co-authorship network of co-authors of Burçak Vural

This figure shows the co-authorship network connecting the top 25 collaborators of Burçak Vural. A scholar is included among the top collaborators of Burçak Vural based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burçak Vural. Burçak Vural is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yazıcı, Hülya, et al.. (2020). A novel 20-gene prognostic score in pancreatic adenocarcinoma. PLoS ONE. 15(4). e0231835–e0231835. 10 indexed citations
4.
Erdağ, Ece, Cem İ̇smail Küçükali, Murat Kürtüncü, et al.. (2019). Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease. In Vivo. 33(5). 1493–1497. 12 indexed citations
5.
Tüzün, Erdem, et al.. (2015). Increased complexin-1 and decreased miR-185 expression levels in Behçet’s disease with and without neurological involvement. Neurological Sciences. 37(3). 411–416. 11 indexed citations
6.
Türkoğlu, Recai, Canan Ulusoy, Ece Erdağ, et al.. (2014). Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression. Medical Principles and Practice. 23(3). 239–245. 3 indexed citations
7.
Ulusoy, Canan, Melike Küçükerden, Arzu Çoban, et al.. (2014). Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study. Inflammation Research. 63(10). 799–801. 4 indexed citations
8.
Erdağ, Ece, Neşe Çelebisoy, Nur Yüceyar, et al.. (2014). Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients. Acta Neurologica Belgica. 115(2). 137–140. 6 indexed citations
9.
Shugaiv, Erkingül, Maria Isabel Leite, Mark Woodhall, et al.. (2013). Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses. European Neurology. 69(5). 257–262. 20 indexed citations
10.
Woodhall, Mark, Patrick Waters, Canan Ulusoy, et al.. (2013). Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies (P02.135). Neurology. 80(7_supplement). 1 indexed citations
11.
Vural, Burçak, Nazlı Yalçınkaya, Melike Küçükerden, et al.. (2013). Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease. Journal of Neuroimmunology. 263(1-2). 139–144. 12 indexed citations
12.
Atalar, Fatmahan, Burçak Vural, Ayşe Demirkan, et al.. (2012). 11β-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease. Genetics and Molecular Research. 11(3). 3122–3132. 8 indexed citations
13.
Vural, Burçak, Fatih Yakar, Duygu Derin, et al.. (2012). Evaluation of Glutathione S-Transferase P1 Polymorphisms (Ile105Val and Ala114Val) in Patients with Small Cell Lung Cancer. Genetic Testing and Molecular Biomarkers. 16(7). 701–706. 10 indexed citations
14.
Vural, Burçak, Erdem Tüzün, Murat Kürtüncü, et al.. (2011). Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease. Journal of Neuroimmunology. 239(1-2). 91–97. 22 indexed citations
15.
Vural, Burçak, Ayşe Demirkan, Bahar Artım-Esen, et al.. (2010). Seroreactivity against PTEN-induced putative kinase 1 (PINK1) in Turkish patients with Behçet's disease.. PubMed. 27(2 Suppl 53). S67–72. 16 indexed citations
16.
Palanduz, Şükrü, Burçak Vural, Kıvanç Çefle, et al.. (2009). Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia. Genetic Testing and Molecular Biomarkers. 13(5). 599–602. 1 indexed citations
17.
Üstüner, Zeki, Pınar Saip, Vildan Yasasever, et al.. (2008). Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients. Medical Oncology. 25(4). 394–399. 32 indexed citations
18.
Vural, Burçak, Fatmahan Atalar, Ayşe Demirkan, et al.. (2008). Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovascular Pathology. 17(6). 392–398. 74 indexed citations
19.
Üstek, Duran, Cumhur Gökhan Ekmekçi, Fatih Selçukbırıcık, et al.. (2006). Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis & Rheumatism. 56(1). 345–350. 22 indexed citations
20.
Vural, Burçak, et al.. (1997). Turkish population data on the HLA-DQα, LDLR, GYPA, HBGG, D7S8, and GC loci. International Journal of Legal Medicine. 111(1). 43–45. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026